In vitro evaluation of the toxicity and underlying molecular mechanisms of Janus Fe3 O4 -TiO2 nanoparticles in human liver cells

Abstract

Recent studies show that Janus Fe₃ O₄ -TiO₂ nanoparticles (NPs) have potential applications as a multifunctional agent of magnetic resonance imaging (MRI) and photodynamic therapy (PDT) for the diagnosis and therapy of cancer. However, little work has been done on their biological effects. To evaluate the toxicity and underlying molecular mechanisms of Janus Fe₃ O₄ -TiO₂ nanoparticles, an in vitro study using a human liver cell line HL-7702 cells was conducted. For comparison, the Janus Fe₃ O₄ -TiO₂ NPs parent material TiO₂ NPs was also evaluated. Results showed that both Fe₃ O₄ -TiO₂ NPs and TiO₂ NPs decreased cell viability and ATP levels when applied in treatment, but increased malonaldehyde (MDA) and reactive oxygen species (ROS) generation. Mitochondria JC-1 staining assay showed that mitochondrial membrane permeability injury occurred in both NPs treated cells. Cell viability analysis showed that TiO₂ NPs induced slightly higher cytotoxicity than Fe₃ O₄ -TiO₂ NPs in HL7702 cells. Western blotting indicated that both TiO₂ NPs and Fe₃ O₄ -TiO₂ NPs could induce apoptosis, inflammation, and carcinogenesis related signal protein alterations. Comparatively, Fe₃ O₄ -TiO₂ NPs induced higher signal protein expressions than TiO₂ NPs under a high treatment dose. However, under a low dose (6.25 μg/cm² ), neither NPs had any significant toxicity on HL7702 cells. In addition, our results suggest both Fe₃ O₄ -TiO₂ NPs and TiO₂ NPs could induce oxidative stress and have a potential carcinogenetic effect in vitro. Further studies are needed to elaborate the detailed mechanisms of toxicity induced by a high dose of Fe₃ O₄ -TiO₂ NPs.

Keywords: HL7702 cells; Janus Fe3O4-TiO2 nanoparticles (NPs); TiO2 NPs; in vitro study; toxicity.